Low-dose candesartan prevents schizophrenia-like behavioral alterations in a neurodevelopmental two-hit model of schizophrenia
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 111, 110348
Abstract
No abstract availableKeywords
Funding Information
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 80 references indexed in Scilit:
- Improving basic and translational science by accounting for litter-to-litter variation in animal modelsBMC Neuroscience, 2013
- Animal models of schizophreniaBritish Journal of Pharmacology, 2011
- Angiotensin II-induced upregulation of AT1 receptor expression: sequential activation of NF-κB and Elk-1 in neuronsAmerican Journal of Physiology-Cell Physiology, 2010
- Common variants conferring risk of schizophrenia: A pathway analysis of GWAS dataSchizophrenia Research, 2010
- The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorderPsychological Medicine, 2010
- Prepulse inhibition and genetic mouse models of schizophreniaBehavioural Brain Research, 2009
- Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology AspectsSchizophrenia Bulletin, 2009
- Extrapolating brain development from experimental species to humansNeuroToxicology, 2007
- Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate MeasuresSchizophrenia Bulletin, 2006
- Deconstructing Schizophrenia: An Overview of the Use of Endophenotypes in Order to Understand a Complex DisorderSchizophrenia Bulletin, 2006